A molecule called metaiodobenzylguanidine (MIBG) is selectively internalized by neuroblastoma cells, and when combined with radiolabeled iodine (iodine-131), MIBG can be used to kill tumour cells. Immunotherapy using antibodies that are directed against neuroblastoma cells also have been tested in clinical trials. Other forms of therapy include synthetic…
Read More
